期刊文献+

回顾性分析单用长效β-激动剂治疗儿童和成人哮喘的疗效 被引量:1

Retrospective analysis the effect of long-acting β-agonist monotherapy on the asthma in children and adults
原文传递
导出
摘要 目的回顾性分析单用长效β-激动剂(LABA)治疗儿童和成人哮喘的疗效。方法对我院呼吸科124例单用LABA治疗患者的医疗档案进行回顾性分析。结果单用LABA治疗的普及率,女性受试者高于男性受试者;普及率随着年龄的增加有所增大。LABA单用治疗的疗效,在各个年龄段间差异有统计学意义(均P<0.01)。结论单用LABA治疗哮喘的疗效不佳,特别是对于年长者。 Objective To retrospective analyze effect of long-acting β-agonist(LABA) monotherapy on asthma in children and adults.Methods Medical records of 124 cases by the use of LABA monotherapy in the pediatrics department of our hospital were retrospectively analyzed.Results In term of the penetration of LABA monotherapy,female subjects are higher than male subjects.The popularization rate in 3 years has been increased with the age increasing.According to the age analysis,the clinical effect of LABA monotherapy among the ages has statistically significant difference(P0.01).Conclusion LABA monotherapy is not good effect,especially for the elderly asthma patients.
作者 王云
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第11期863-864,共2页 The Chinese Journal of Clinical Pharmacology
关键词 哮喘 长效β-激动剂 asthma long-acting β-agonists
  • 相关文献

参考文献7

  • 1Jacobsen JR. Third - generation long - acting 13 ( 2 ) - adrenoceptor agonists:medicinal chemistry strategies employed in the identification of once - daily inhaled 13 ( 2 ) - adrenoceptor agonists [ J ]. Future Med Chem,2011 ;3 : 1607 - 1622.
  • 2Procopiou PA, Barrett V J, Ford A J, et al. The discovery of long - acting saligenin β (2) adrenergic receptor agonists incorporating a urea group [ J ]. Bioorg Med Chem, 2011 ; 19:6026 - 6032.
  • 3Bateman ED, Rabe KF, Calverley PM, et al. Roflumilast with long - acting 132 - agonists for COPD : influence of exacerbation history [ J]. Eur Respir J,2011 ;38:553 - 560.
  • 4李文开,李云,钟礼立.全反视黄酸对哮喘大鼠气道反应性和气道重塑的影响[J].中国当代儿科杂志,2011,13(10):827-831. 被引量:5
  • 5Pinelli NR, Hurren KM. Efficacy and safety of long - acting glucagon - like peptide - 1 receptor agonists compared with excnatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta - analysis [ J]. Ann Pharmacother ,2011;45 :850 - 860.
  • 6Connolly S,Alcaraz L,Bailey A,et al. Design -driven LO: the dis- covery of new ultra long acting dibasic β2 - adrenoceptor agonists [ J]. Bioorg Med Chem Lett,2011 ;21:4612 -4616.
  • 7Procopiou PA, Barrett VJ, Bevan N J, et al. The discovery of long - acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings [ J]. Bioorg Med Chem,2011 ;19:4192 -4201.

二级参考文献14

  • 1Mookerjee I, Hewitson TD, Hails ML, Summers RJ, Mathai ML, Bathgate RA, et al. Relaxin family peptide receptor-1 protects against airway fibrosis during homeostasis but not against fibrosis associated with chronic allergic airways disease [ J ]. Endocrinology, 2009, 150(3) :1495-1502.
  • 2Locke NR, Royce SG, Wainewright JS, Samuel CS, Tang ML. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease [J]. J Immunol, 2006, 176 ( 11 ) :6553-6559.
  • 3Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma : selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen [ J ]. Thorax, 1998, 53(10) :849-856.
  • 4Shen H, O'Byrne PM, Ellis R, Wattie J, Tang C, Inman MD. The effects of intranasal budesonide on allergen-induced production of interleukin-5 and eotaxin, airways, blood, and bone marrow eosinophilia, and eosinophil progenitor expansion in sensitized mice [ J ]. Respir Crit Care Med, 2002, 166 (2) : 146-153.
  • 5Yamauchi K, Inoue H. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling [J]. Allergol Int, 2007, 56(4) :321-329.
  • 6Ohbayashi H, Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma [ J ]. Curr Drug Targets Inflamm Allergy, 2005, 4(2) :177-181.
  • 7Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis[J]. Respir Crit Care Med, 1998, 158 ( 6 ) : 1945-1950.
  • 8Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling[J]. Respir Cell Mol Biol, 2003, 28 ( 1 ) : 12-24.
  • 9Araujo BB, Dolhnikoff M, Silva LF, Elliot J, Lindeman JH, Ferreira DS, et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma[J]. Eur Respir J, 2008, 32 (1) :61-69.
  • 10Margulis A, Nocka KH, Brennan AM, Deng B, Fleming M, Goldman SJ, et al. Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels : influence of cytokines, matrix metalloproteases, and serine proteases[J]. J Immunol, 2009, 183(3) : 1739-1750.

共引文献4

同被引文献9

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部